Scrutiny Grows of Drug Trials Abroad

December 2, 2008

Western pharmaceutical companies are facing intensifying scrutiny over the conduct of clinical trials in developing countries — an increasingly important source of patients to test new drugs and get them to the market. (Wall Street Journal)